MICHELLE VISSING: Open Payments
NPI 1740849637 · JEFFERSONVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,132 in 172 payments from 25 companies in 2025. Trend: 2023 $3,300 · 2024 $3,494 · 2025 $5,132
Food & beverage: $3,037Speaker / faculty: $2,000Travel & lodging: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $2,530 |
| AstraZeneca Pharmaceuticals LP | 12 | $444 |
| Bayer Healthcare Pharmaceuticals Inc. | 15 | $243 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $233 |
| GlaxoSmithKline, LLC. | 15 | $227 |
| Axsome Therapeutics, Inc. | 13 | $206 |
| Viatris Specialty LLC | 7 | $164 |
| Alkermes, Inc. | 19 | $161 |
| Otsuka America Pharmaceutical, Inc. | 12 | $158 |
| Amgen Inc. | 6 | $91 |
Products named: VRAYLAR, AIRSUPRA, Kerendia, CAPLYTA, TRELEGY ELLIPTA, Auvelity, REXULTI, YUPELRI.
Industry payments across IN — which companies pay providers there.
